Scinai Immunotherapeutics (SCNI) Cash from Operations (2018 - 2026)
Scinai Immunotherapeutics (SCNI) reported Cash from Operations of 1456000.0 for Q1 2026, down 39.87% on a YoY basis from 2421239.62 in Q1 2025, and up 5.08% sequentially from 1534000.0 in Q2 2025.
Scinai Immunotherapeutics (SCNI) Cash from Operations (2018 - 2026) Analysis & Trends
Scinai Immunotherapeutics (SCNI) has 9 years of Cash from Operations data on file, last reported at 1456000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations fell 39.87% year-over-year to 1456000.0; the trailing twelve-month figure through Mar 2026 stood at 5107000.0 (up 13.63% YoY), and the FY2025 full-year result was 6031000.0, up 4.8% from the prior year.
- Cash from Operations rose to 1456000.0 in Q1 2026, from 1534000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 593000.0 in Q4 2022 to a low of 3665000.0 in Q2 2022.
- A 5-year average of 1800866.67 and a median of 1534000.0 in 2025 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations surged 69.26% in 2022 and slumped 176.83% in 2023, its largest moves.
- Tracing SCNI's Cash from Operations over 5 years: stood at 593000.0 in 2022, then sank by 106.58% to 1225000.0 in 2023, then grew by 12.16% to 1076000.0 in 2024, then sank by 42.57% to 1534000.0 in 2025, then increased by 5.08% to 1456000.0 in 2026.
- Business Quant data shows SCNI's Cash from Operations at 1456000.0 in Q1 2026, 1534000.0 in Q2 2025, and 1041000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Scinai Immunotherapeutics | 352,860.00 | -3.11 Bn | -1.12 Mn | -1.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.46 Mn |
| Mar 31, 2026 | -1.46 Mn |
| Jun 30, 2025 | -1.53 Mn |
| Jun 30, 2025 | -1.53 Mn |
| Mar 31, 2025 | -1.04 Mn |
| Mar 31, 2025 | -1.04 Mn |
| Dec 31, 2024 | -1.08 Mn |
| Dec 31, 2024 | -1.08 Mn |
| Sep 30, 2024 | -2.04 Mn |
| Sep 30, 2024 | -2.04 Mn |
| Jun 30, 2024 | -1.76 Mn |
| Jun 30, 2024 | -1.76 Mn |
| Mar 31, 2024 | -1.46 Mn |
| Mar 31, 2024 | -1.46 Mn |
| Dec 31, 2023 | -1.23 Mn |
| Dec 31, 2023 | -1.23 Mn |
| Sep 30, 2023 | -2.22 Mn |
| Sep 30, 2023 | -2.22 Mn |
| Jun 30, 2023 | -2.88 Mn |
| Jun 30, 2023 | -2.88 Mn |